These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28434763)

  • 1. Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.
    Gomes MN; Alcântara LM; Neves BJ; Melo-Filho CC; Freitas-Junior LH; Moraes CB; Ma R; Franzblau SG; Muratov E; Andrade CH
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2459-2464. PubMed ID: 28434763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and activity of benzopiperidine, benzopyridine and phenyl piperazine based compounds against Leishmania infantum.
    Chander S; Ashok P; Reguera RM; Perez-Pertejo MY; Carbajo-Andres R; Balana-Fouce R; Gowri Chandra Sekhar KV; Sankaranarayanan M
    Exp Parasitol; 2018 Jun; 189():49-60. PubMed ID: 29702355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives.
    Barea C; Pabón A; Galiano S; Pérez-Silanes S; Gonzalez G; Deyssard C; Monge A; Deharo E; Aldana I
    Molecules; 2012 Aug; 17(8):9451-61. PubMed ID: 22871647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Targets for Chalcones in Antileishmanial Drug Discovery.
    de Santiago-Silva KM; da Silva Gomes GF; Perez CC; da Silva Lima CH; de Lima Ferreira Bispo M
    Mini Rev Med Chem; 2023; 23(14):1414-1434. PubMed ID: 36705240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.
    Scala A; Cordaro M; Grassi G; Piperno A; Barberi G; Cascio A; Risitano F
    Bioorg Med Chem; 2014 Feb; 22(3):1063-9. PubMed ID: 24433962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2',4'-dihydroxychalcone could be explored to develop new inhibitors against the glycerol-3-phosphate dehydrogenase from Leishmania species.
    Passalacqua TG; Torres FA; Nogueira CT; de Almeida L; Del Cistia ML; dos Santos MB; Dutra LA; Bolzani VS; Regasini LO; Graminha MA; Marchetto R; Zottis A
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3564-8. PubMed ID: 26169126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide.
    Kannigadu C; Aucamp J; N'Da DD
    Drug Dev Res; 2021 Apr; 82(2):287-295. PubMed ID: 33141473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity.
    de Oliveira NS; de Souza LG; de Almeida VM; Barreto ARR; Carvalho-Gondim F; Schaeffer E; Santos-Filho OA; Rossi-Bergmann B; da Silva AJM
    Arch Pharm (Weinheim); 2024 Mar; 357(3):e2300440. PubMed ID: 38048546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.
    de Almeida L; Passalacqua TG; Dutra LA; Fonseca JNVD; Nascimento RFQ; Imamura KB; de Andrade CR; Dos Santos JL; Graminha MAS
    Biomed Pharmacother; 2017 Nov; 95():536-547. PubMed ID: 28866421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzimidazole derivatives endowed with potent antileishmanial activity.
    Tonelli M; Gabriele E; Piazza F; Basilico N; Parapini S; Tasso B; Loddo R; Sparatore F; Sparatore A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):210-226. PubMed ID: 29233048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.
    Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; González M; Rubiales G; Palacios F
    Eur J Med Chem; 2018 May; 152():137-147. PubMed ID: 29704722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemotherapeutic potential of chalcones against leishmaniases: a review.
    Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA
    Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approved drugs successfully repurposed against
    Oualha R; Abdelkrim YZ; Guizani I; Harigua-Souiai E
    Front Cell Infect Microbiol; 2024; 14():1403589. PubMed ID: 39391884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
    Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
    Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, leishmanicidal and cytotoxic activity of triclosan-chalcone, triclosan-chromone and triclosan-coumarin hybrids.
    Otero E; Vergara S; Robledo SM; Cardona W; Carda M; Vélez ID; Rojas C; Otálvaro F
    Molecules; 2014 Aug; 19(9):13251-66. PubMed ID: 25170948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-
    Mendes EP; Goulart CM; Chaves OA; Faiões VDS; Canto-Carvalho MM; Machado GC; Torres-Santos EC; Echevarria A
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.